| Date | Time | Source | Headline | Symbol | Company |
| 02/13/2008 | 12:45PM | Edgar (US Regulatory) | Avi Biopharma Inc - Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/12/2008 | 6:31PM | Edgar (US Regulatory) | Avi Biopharma Inc - Initial Statement of Beneficial Ownership (3) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/12/2008 | 6:30PM | Edgar (US Regulatory) | Avi Biopharma Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/11/2008 | 9:00AM | Business Wire | AVI BioPharma Names Dr. Leslie Hudson as Chief Executive Officer | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/07/2008 | 12:28PM | Edgar (US Regulatory) | Avi Biopharma Inc - Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/10/2008 | 4:58PM | Edgar (US Regulatory) | Avi Biopharma Inc - Initial Statement of Beneficial Ownership (3) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/21/2007 | 3:08PM | Business Wire | AVI BioPharma Announces Commencement of Dosing in Clinical Trial for Duchenne Muscular Dystrophy | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/19/2007 | 4:05PM | Business Wire | AVI BioPharma, Inc. Completes Registered Direct Offering, Raises $20.3 Million | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/13/2007 | 9:05AM | Edgar (US Regulatory) | Avi Biopharma Inc - Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/13/2007 | 9:02AM | Edgar (US Regulatory) | Avi Biopharma Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/13/2007 | 8:52AM | Business Wire | AVI BioPharma, Inc. to Raise $20.3 Million in Registered Direct Offering | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/13/2007 | 6:04AM | Edgar (US Regulatory) | Avi Biopharma Inc - Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/05/2007 | 3:16PM | Edgar (US Regulatory) | Avi Biopharma Inc - Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/09/2007 | 1:21PM | Edgar (US Regulatory) | Avi Biopharma Inc - Quarterly Report (10-Q) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/09/2007 | 1:21PM | Edgar (US Regulatory) | Avi Biopharma Inc - Quarterly Report (10-Q) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/08/2007 | 4:09PM | Edgar (US Regulatory) | Avi Biopharma Inc - Initial Statement of Beneficial Ownership (3) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/08/2007 | 4:09PM | Edgar (US Regulatory) | Avi Biopharma Inc - Initial Statement of Beneficial Ownership (3) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/05/2007 | 1:48PM | Edgar (US Regulatory) | Avi Biopharma Inc - Amended Annual Report (10-K/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/05/2007 | 1:48PM | Edgar (US Regulatory) | Avi Biopharma Inc - Amended Quarterly Report (10-Q/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/05/2007 | 1:47PM | Edgar (US Regulatory) | Avi Biopharma Inc - Amended Quarterly Report (10-Q/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/30/2007 | 5:07PM | Edgar (US Regulatory) | Avi Biopharma Inc - Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/30/2007 | 5:07PM | Edgar (US Regulatory) | Avi Biopharma Inc - Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/24/2007 | 4:15PM | Edgar (US Regulatory) | Avi Biopharma Inc - Current report filing | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/24/2007 | 4:15PM | Edgar (US Regulatory) | Avi Biopharma Inc - Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 08/08/2007 | 4:05AM | Business Wire | AVI BioPharma Announces Second Quarter Financial Results | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 08/08/2007 | 4:00AM | Business Wire | AVI BioPharma Announces Refocused Clinical Development Strategy | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 08/01/2007 | 1:47PM | Business Wire | AVI BioPharma Announces 2007 Second Quarter Financial Results Conference Call | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 07/25/2007 | 9:08AM | Business Wire | AVI BioPharma Partner Global Therapeutics Announces Positive Pre-Clinical Results Shown Using NEUGENE Antisense Drug in Preventi | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 07/17/2007 | 9:00AM | Business Wire | AVI BioPharma Announces Positive Pre-Clinical Study Results Presented at the 26th Annual Meeting of the American Society for Vir | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 07/10/2007 | 9:00AM | Business Wire | AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatmen | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |